| Literature DB >> 28962377 |
Heisanam Pushparani Devi1, P B Mazumder1, Laishram Priyadarshini Devi1.
Abstract
The rhizomes of Curcuma caesia Roxb. (zingiberacea) are traditionally used in treatment of various ailments and metabolic disorders like leukoderma, asthma, tumours, piles, bronchitis, etc. in Indian system of medicine. Considering the importance of natural products in modern phytomedicine, the antioxidant and antimutagenic activities of C. caesia Roxb. rhizome extract and its fractions were evaluated. The ethanolic fraction showed highest antioxidant activity by DPPH assay (86.91%) comparable to ascorbic acid (94.77%) with IC50 value of 418 μg/ml for EECC followed by MECC (441.90 μg/ml) > EAECC(561 μg/ml) > AECC(591 μg/ml). Based on the antioxidant activity, three of the rhizome extracts were evaluated for their antimutagenic properties against indirect acting mutagen cyclophosphamide (CP) using Salmonella typhimurium strains TA98 and TA100. The antimutagenic activity of the extracts against indirect acting mutagen cyclophosphamide in the presence of mammalian metabolic activation system was found to be significant (p < 0.01, p < 0.05). All the extracts showed similar antimutagenicity in dose dependent manner. The total phenolic content as well as reducing ability of the extracts was also determined.Entities:
Keywords: Antimutagenic activity; Antioxidant activity; Ascorbic acid (PubChem CID: 54670067); Curcuma caesia Roxb.; Cyclophosphamide; Cyclophosphamide (PubChem CID: 2907); DPPH (PubChem CID: 2735032); FeCl3 (PubChem CID: 24380); Gallic acid (PubChem CID: 370); KCl (PubChem CID: 4873); NaHCO3 (PubChem CID: 516892); Reducing power; TCA (PubChem CID: 6421); Total phenolic content; d-Biotin (PubChem CID: 171548); l-Histidine (PubChem CID: 6274); α-d-Glucose-6-P (PubChem CID: 439284)
Year: 2015 PMID: 28962377 PMCID: PMC5598318 DOI: 10.1016/j.toxrep.2014.12.018
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1DPPH method. EECC: ethanolic extract of Curcuma caesia Roxb., MECC: methanolic extract of Curcuma caesia Roxb., EaECC: ethyl acetate extract of Curcuma caesia Roxb., AECC: aqueous extract of Curcuma caesia Roxb.
Fig. 2Standard curve of gallic acid to find out the total phenolic content.
Reducing power of the extracts.
| Conc (μg/ml) | EECC | MECC | EaECC | AECC |
|---|---|---|---|---|
| 1000 | 2.480 ± 0.010 | 1.639 ± 0.029 | 0.899 ± 0.053 | 0.348 ± 0.023 |
| 800 | 2.277 ± 0.068 | 1.368 ± 0.029 | 0.468 ± 0.028 | 0.275 ± 0.015 |
| 500 | 1.511 ± 0.041 | 0.788 ± 0.005 | 0.333 ± 0.022 | 0.180 ± 0.009 |
| 200 | 0.775 ± 0.002 | 0.372 ± 0.001 | 0.159 ± 0.013 | 0.074 ± 0.002 |
| Ascorbic acid (200 μg/ml) | 2.425 ± 0.03 |
Number of his+ revertants in Salmonella typhimurium strains produced by Curcuma caesia Roxb. extracts against cyclophosphamide.
| Treatment conc. (μg/ml) | TA98 | TA100 | ||
|---|---|---|---|---|
| −S9 | +S9 | −S9 | +S9 | |
| S.R | 92.66 ± 6.94 | 304 ± 23 | 55 ± 4.54 | 213 ± 13.06 |
| P.C: 50 | 299.66 ± 26.44 | 718 ± 94 | 135.66 ± 19.36 | 652.66 ± 71.2 |
| EECC: 50 | 116.33 ± 18.14 | 395.11 ± 71.2 | 98 ± 10.42 | 398.66 ± 64.8 |
| 500 | 111.33 ± 19.14 | 386.51 ± 74 | 80.33 ± 10.63 | 379.33 ± 63.8 |
| 5000 | 104.33 ± 21.14 | 341.45 ± 93.72 | 71 ± 16.63 | 334.66 ± 86.51 |
| MECC: 50 | 179.66 ± 39.98 | 491.67 ± 98.28 | 126.66 ± 3.39 | 434.33 ± 44.93 |
| 500 | 163.66 ± 47.6 | 487.66 ± 56 | 105.66 ± 5.39 | 412.33 ± 43.4 |
| 5000 | 144.66 ± 13.55 | 401.66 ± 93.14 | 91.66 ± 10.17 | 385.33 ± 74 |
| ECC: 50 | 221.66 ± 15.9 | 596.67 | 131.33 ± 3.86 | 466.33 ± 21.7 |
| 500 | 211.33 ± 22.89 | 562.67 ± 3.5 | 121 ± 5.54 | 449.66 ± 45.7 |
| 5000 | 95.66 ± 31.56 | 479.66 ± 33.15 | 97.66 ± 9.74 | 410.66 ± 51.8 |
The data represented in the table is the mean ± S.D. values of three replicates.
p < 0.01.
p < 0.05.
EECC: ethanolic extract of Curcuma caesia Roxb.; MECC: methanolic extract of Curcuma caesia Roxb.; AECC: aqueous extract of Curcuma caesia Roxb.; P.C: positive control; C.P: cyclophosphamide; S.R: spontaneous revertants.